For Immediate Release Chicago, IL – June 23, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Whole Foods (NASDAQ: WFM – Free Report ), Amazon (NASDAQ: AMZN – Free Report ), Xcerra (NASDAQ: XCRA – Free Report ) and Synernon Medical (NASDAQ: ELOS – Free Report ). Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free . Here are highlights from Thursday’s Analyst Blog: Waiting For Bigger Bids? There are several stocks in “holding patterns” due to announced M&A deals. A company may have accepted an offer to be acquired but that won’t stop the speculators from paying an even higher price in anticipation of a better bid coming from a “white knight.” The most obvious instance for this is Whole Foods (NASDAQ: WFM – Free Report ) which traded $43.64 on Monday, June 19 following the Friday, June 16 news that it would be acquired by Amazon (NASDAQ: AMZN – Free Report ) for $42 per share. The $1.64 over the deal price was Wall Street’s way of saying a higher bid could be coming, but will it? The WFM and AMZN deal has a break up fee of $400M which would have to be paid to AMZN, so at 2.9% of the total deal it is not out of the question. There has been plenty of speculation about private equity names coming in and making a stronger offer. That bigger bid could make Amazon pay a higher price, but it could also draw the ire of Jeff Bezos and that isn’t a spot I would want to be in. The end result is you have to expect that bigger bid if you are buying WFM here. A Better Play Xcerra (NASDAQ:XCRA – Free Report ) was added to my Stocks Under $10 Investor portfolio on February 15 at about $7.82. The stock was a Zacks Rank #1 (Strong Buy) at the time as earnings estimates were trending higher. Revenue was projected to grow around 11% and the price to book multiple was only a fraction of the industry average. On April 10 the company announced that it would be acquired by Unic Capital Management for $10.25 per share. The deal needs to be approved and that has yet to happen, but the stock is still trading well below the deal price. What is more, XCRA reported a very good quarter on June 1, topping estimates on top and on the bottom line. A Missed Opportunity Another stock in the service that I manage was being acquired and traded above the announced price. Synernon Medical (NASDAQ: ELOS – Free Report ) traded up to $11.25 when the announced deal price was only $11. The company was given some time to find a superior bid, but no other bidder materialized. The stock slide into the expiration of the “go-shop” period and now I am holding this stock into the deal as it has recovered to trade within a dime of the deal price. Strong Stocks that Should Be in the News Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>. Get the full Report on WFM - FREE Get the full Report on AMZN - FREE Get the full Report on XCRA - FREE Get the full Report on ELOS - FREE Follow us on Twitter: https://twitter.com/zacksresearch!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs"); Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Re... Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@zacks.com https://www.zacks.com/ Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Whole Foods Market, Inc. (WFM): Free Stock Analysis Report Amazon.com, Inc. (AMZN): Free Stock Analysis Report Xcerra Corporation (XCRA): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research